Article Listing - Strong data from MDV3100 prostate cancer trial lead Medivation and Astellas to stop study early

US FDA IMPORT DETENTIONS

13 April 1992

In the first quarter of fiscal 1992, running from October to December 31, 1991, US Food and Drug Administra-tion officials...

GERMAN BPI: MORE PATIENT CHARGES

13 April 1992

The German pharmaceutical industry association, the BPI, has called for the principle under which patients contribute to the cost of...

SUSPENSION OF DPT VACCINE

13 April 1992

Following the decision by the Department of Health in the Republic of China for an immediate temporary suspension of the...

FORTHCOMING MEETINGS

13 April 1992

Pharmaceutical industry meetings to be held in London by Management Forum shortly include:

- Improving Drug Development: Principles and Practice of...

UPJOHN UPDATES ON R&D PROGRESS

13 April 1992

As the 1990s progress, US pharmaceutical company Upjohn faces a situation where several of its high-earning products will come to...

ZOVIRAX AND SHINGLES

13 April 1992

Wellcome's Zovirax (aciclovir) should only be used to treat shingles if patients are immunocompromised, according to the UK Medicines...

CONTINENTAL CLOSES BIOLOGICALS DIVISION SALE

13 April 1992

Continental Pharma Cryosan Inc reports that it has received a cash payment of $16.9 million on closing the sale of...

HOECHST JAPAN MERGERS?

13 April 1992

Hoechst Japan Ltd has proposed that in order to strengthen its operation in the next five years it will examine...

NOVO-NORDISK'S rec INSULIN LAUNCHED IN FRANCE

13 April 1992

Novo-Nordisk has launched four formulations of its recombinant human insulin under the trade name Mixtard HMge Penfill. All the formulations...

CERVOXAN 60mg LAUNCHED IN FRANCE

13 April 1992

Laboratoires Sobio, which is part of SmithKline Beecham, has launched a new 60mg oral formulation of Cervoxan (vinburnine) its cerebral/peripheral...

Showing 94591-94600 of 95586 articles

Go to beginningPreviousNextGo to end